FDA Approves RSV Drug For Babies And Toddlers At Risk

Name: FDA Approves RSV Drug For Babies And Toddlers At Risk
Uploaded: 2023-07-18T15:20:17.000Z
Channel: The Weather Channel
Description: The Food and Drug Administration approved Beyfortus, an injectible medicine that contains RSV antibodies. The drug is intended to help infants and toddlers...

ByTWC - Digital•

October 15, 2024

Updated: October 15, 2024, 12:00 pm EDTPublished: July 18, 2023, 11:20 am EDT

The Food and Drug Administration approved Beyfortus, an injectible medicine that contains RSV antibodies. The drug is intended to help infants and toddlers under 2 years old fight off the virus.